BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Drug Development

  Bicycle Therapeutics and Cancer Research UK Announce Initiation of First Clinical Study of a Bicyclic Peptide (Bicycle)

  Bicycle Therapeutics and Cancer Research UK announced today that the first patient has been dosed in their Phase I/IIa trial evaluating BT1718 in patients with advanced solid tumors.

  February 13, 2018

   · 

  7 min read
• Business

  Oxford Immunotec Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018

  Management will host a conference call to review the Company’s results at 8:00 a.m. Eastern Time the same day.

  February 13, 2018

   · 

  3 min read
• ABiL Develops Ultrafast Genomic Algorithm, Exceeds $2M in Revenue

  This increased speed will bring improvements in the diagnosis of cancer, genetic diseases, and antibiotic resistant infections, stimulating the development of genomic approaches to healthcare.

  February 13, 2018

   · 

  2 min read
• Business

  Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights

  The call can be accessed by dialing (855) 851-4526 (domestic) or (720) 634-2901 (international), and entering passcode 9596288.

  February 13, 2018

   · 

  1 min read
• Business

  Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1

  The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international).

  February 13, 2018

   · 

  4 min read
• Conversion of FIT Biotech Oy’s Convertible Capital Notes Into Shares - Feb. 13, 2018

  The Board authorization is based on the Extraordinary General Meeting December 14, 2017.

  February 13, 2018

   · 

  1 min read
• Median Technologies Announces Results of Deep Learning Study for Enhanced Prostate Segmentation - Helping to Advance Precision Medicine

  Study results will be presented at the SPIE Medical Imaging conference in Houston, TX, USA on February 14.

  February 13, 2018

   · 

  3 min read
• GN Store Nord: Transactions in Relation to Share Buyback Program – Feb. 13, 2018

  The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

  February 13, 2018

   · 

  2 min read
• Business

  BerGenBio ASA: Results for the Fourth Quarter and Full Year 2017

  A presentation of the results by the Company’s senior management team will take place today at 10.00 am CET in Oslo - details below.

  February 13, 2018

   · 

  7 min read
• Biotech Beach

  Oracle Argus Supports E2B(R3) Exchange with the EMA’s Enhanced EudraVigilance System

  Both Oracle Argus cloud and on-premise deployments have been tested and are fully compliant with the new EV system.

  February 13, 2018

   · 

  2 min read